JESSICA P HWANG to Hepatitis B Surface Antigens
This is a "connection" page, showing publications JESSICA P HWANG has written about Hepatitis B Surface Antigens.
Connection Strength
0.700
-
Hepatitis B reactivation after chemoimmunotherapy: screen before treatment. Lancet. 2021 02 06; 397(10273):510.
Score: 0.192
-
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol. 2020 11 01; 38(31):3698-3715.
Score: 0.185
-
Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012 Nov; 20(11):2999-3008.
Score: 0.107
-
Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012 Jul; 8(4):e32-9.
Score: 0.106
-
False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385.
Score: 0.055
-
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int. 2023 04; 17(2):509-511.
Score: 0.055